v3.26.1
SCHEDULE OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT (Details) - USD ($)
$ in Thousands
 12 Months Ended
Mar. 27, 2026
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Line Items]      
Revenues   $ 7,679 $ 3,705
Cost of revenues   (7,427) (5,368)
Research and development   (10,241) (16,857)
Selling, general, and administrative   (19,055) (26,017)
Loss from operations   (29,044) (44,537)
Interest and finance expense   (3,515) (3,019)
Other non-operating income/(expense)   (14) 9
Net loss before income taxes   (33,249) (46,625)
Depreciation and amortization   3,100 3,000
Total stock-based compensation expense $ 100 5,282 9,146
Cash used in operations   (18,144) (38,218)
Cash provided by investing   (3,674) 14,905
Cash provided by financing   29,090 16,646
Impact of exchange rates   194 (45)
Net change for the year   7,466 (6,712)
Cash, cash equivalents and marketable securities   17,263 7,148
TOTAL ASSETS   35,385 30,062
Total liabilities   (29,175) (15,721)
Non-controlling interest   84 758
Business Segment [Member] | Variable Interest Entities [Member] | Parent Company [Member]      
Segment Reporting [Line Items]      
Capital expenditures   1,026 5,883
Revenues   7,679 3,705
Cost of revenues   (7,427) (5,368)
Research and development   (10,241) (16,857)
Selling, general, and administrative   (19,055) (26,017)
Loss from operations   (29,044) (44,537)
Interest and finance expense   (3,515) (3,019)
Other non-operating income/(expense)   (1,775) (923)
Net loss before income taxes   (34,334) (48,479)
Depreciation and amortization   3,251 3,204
Total stock-based compensation expense   5,282 9,146
Cash used in operations   (18,144) (38,218)
Cash provided by investing   (3,674) 14,905
Cash provided by financing   29,090 16,646
Impact of exchange rates   194 (45)
Net change for the year   7,466 (6,712)
Cash, cash equivalents and marketable securities   11,641 6,917
All other assets   23,744 23,145
TOTAL ASSETS   35,385 30,062
Total liabilities   (29,175) (15,721)
Net assets   6,210 14,341
Non-controlling interest   84 758
Beyond Air [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting [Line Items]      
Capital expenditures   1,024 5,859
Revenues   7,679 3,705
Cost of revenues   (7,427) (5,368)
Research and development   (7,677) (13,780)
Selling, general, and administrative   (15,418) (19,565)
Loss from operations   (22,843) (35,008)
Interest and finance expense   (3,515) (3,019)
Other non-operating income/(expense)   (1,668) (1,132)
Net loss before income taxes   (28,026) (39,159)
Depreciation and amortization   3,228 3,143
Total stock-based compensation expense   3,813 7,920
Cash used in operations   (14,775) (29,599)
Cash provided by investing   (4,660) 11,844
Cash provided by financing   28,390 14,646
Impact of exchange rates   228 (39)
Net change for the year   9,183 (3,148)
Cash, cash equivalents and marketable securities   10,140 2,750
All other assets   23,901 22,116
TOTAL ASSETS   34,041 24,866
Total liabilities   (28,224) (15,082)
Net assets   5,817 9,784
Non-controlling interest  
Beyond Cancer Ltd [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting [Line Items]      
Capital expenditures   24
Revenues  
Cost of revenues  
Research and development   (1,170) (3,062)
Selling, general, and administrative   (2,207) (6,344)
Loss from operations   (3,377) (9,406)
Interest and finance expense  
Other non-operating income/(expense)   (323) 209
Net loss before income taxes   (3,700) (9,197)
Depreciation and amortization   23 61
Total stock-based compensation expense   1,373 1,154
Cash used in operations   (1,314) (8,619)
Cash provided by investing   988 3,061
Cash provided by financing  
Impact of exchange rates   164 (6)
Net change for the year   (162) (5,564)
Cash, cash equivalents and marketable securities   1,043 2,167
All other assets   (219) 1,029
TOTAL ASSETS   824 3,196
Total liabilities   (378) (589)
Net assets   446 2,607
Non-controlling interest   64 529
NeuroNos Ltd [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting [Line Items]      
Capital expenditures   2
Revenues  
Cost of revenues  
Research and development   (1,394) (15)
Selling, general, and administrative   (1,430) (108)
Loss from operations   (2,824) (123)
Interest and finance expense  
Other non-operating income/(expense)   216
Net loss before income taxes   (2,608) (123)
Depreciation and amortization  
Total stock-based compensation expense   96 72
Cash used in operations   (2,055)
Cash provided by investing   (2)
Cash provided by financing   700 2,000
Impact of exchange rates   (198)
Net change for the year   (1,555) 2,000
Cash, cash equivalents and marketable securities   458 2,000
All other assets   62
TOTAL ASSETS   520 2,000
Total liabilities   (573) (50)
Net assets   (53) 1,950
Non-controlling interest   $ 20 $ 229